Table 6

Deterministic analysis for the HAPO (four centres) population with NICE risk factors (n=3549)

Diagnostic thresholdCost*QALY*Incremental costIncremental QALYICER
No treatment£00.00n/an/an/a
NICE 2015£546 34926.78£546 34926.78£23 073
WHO 2013£778 99334.35£254 3767.57£37 669
  • *Costs and QALYs are measured relative to a baseline of no treatment.

  • HAPO, Hyperglycaemia and Adverse Pregnancy Outcomes; ICER, incremental cost-effectiveness ratio; NICE, National Institute for Health and Care Excellence; QALY, quality-adjusted life year.